The present disclosure provides a panel of biomarkers for use in diagnosing and/or monitoring kidney health during a therapeutic treatment for a therapeutic regimen that induces renal impairment or chronic kidney disease. Such monitoring may be useful in subjects undergoing treatment a disease such as diabetes mellitus and/or hypertension, where a therapeutic regimen results in increased levels of blood creatinine.
BIOMARKER PANEL FOR MONITORING KIDNEY HEALTH